157 related articles for article (PubMed ID: 36977546)
1. Implantable cardioverter-defibrillator shocks during long-term follow-up in arrhythmogenic right ventricular cardiomyopathy.
Muller SA; Te Riele ASJM
Heart; 2023 Jul; 109(15):1126-1127. PubMed ID: 36977546
[No Abstract] [Full Text] [Related]
2. Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
Molitor N; Hofer D; Çimen T; Gasperetti A; Akdis D; Costa S; Jenni R; Breitenstein A; Wolber T; Winnik S; Fokstuen S; Fu G; Medeiros-Domingo A; Ruschitzka F; Brunckhorst C; Duru F; Saguner AM
Heart; 2023 Jul; 109(15):1146-1152. PubMed ID: 36889907
[TBL] [Abstract][Full Text] [Related]
3. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
[TBL] [Abstract][Full Text] [Related]
4. Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.
Christensen AH; Platonov PG; Svensson A; Jensen HK; Rootwelt-Norberg C; Dahlberg P; Madsen T; Frederiksen TC; Heliö T; Haugaa KH; Bundgaard H; Svendsen JH
Europace; 2022 Feb; 24(2):306-312. PubMed ID: 34279601
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Orgeron GM; Crosson JE
Cardiol Young; 2017 Jan; 27(S1):S57-S61. PubMed ID: 28084951
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry.
Migliore F; Viani S; Bongiorni MG; Zorzi A; Silvetti MS; Francia P; D'Onofrio A; De Franceschi P; Sala S; Donzelli S; Ricciardi G; Menardi E; Giammaria M; La Greca C; Bauce B; Rigato I; Iliceto S; Bertaglia E; Diemberger I; Corrado D
Int J Cardiol; 2019 Apr; 280():74-79. PubMed ID: 30661851
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous Implantable Cardioverter-Defibrillator and Arrhythmogenic Right Ventricular Cardiomyopathy: The Importance of Repeat ECG Screening During Exercise Test.
Migliore F; Bertaglia E; Zorzi A; Corrado D
JACC Clin Electrophysiol; 2017 Jul; 3(7):785-786. PubMed ID: 29759546
[No Abstract] [Full Text] [Related]
10. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators.
Link MS; Wang PJ; Haugh CJ; Homoud MK; Foote CB; Costeas XB; Estes NA
J Interv Card Electrophysiol; 1997 Feb; 1(1):41-8. PubMed ID: 9869950
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and therapy of arrhythmogenic right ventricular cardiomyopathy].
Zorzi A; Rigato I; Migliore F; Perazzolo Marra M; Basso C; Thiene G; Bauce B; Corrado D
G Ital Cardiol (Rome); 2014 Nov; 15(11):616-25. PubMed ID: 25424140
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification for sudden death in arrhythmogenic right ventricular cardiomyopathy.
Cadrin-Tourigny J; Tadros R; Talajic M; Rivard L; Abadir S; Khairy P
Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):653-64. PubMed ID: 25947965
[TBL] [Abstract][Full Text] [Related]
14. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy.
Inciardi RM; Rotolo A; Coppola G; Clemenza F; Giordano U; Lombardo E; Schicchi R; Torcivia R; Arrotti S; Leggio G; Novo S; Assennato P
Int J Cardiol; 2014 Apr; 172(3):e468-9. PubMed ID: 24485618
[No Abstract] [Full Text] [Related]
17. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
[TBL] [Abstract][Full Text] [Related]
18. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis of patients with arrhythmogenic right ventricular cardiomyopathy and implantable defibrillator.
Ruiz-Salas A; Cabrera-Bueno F; García-Pinilla JM; Barrera-Cordero A; Peña-Hernández J; Fernández-Pastor J; Medina-Palomo C; Alzueta-Rodríguez J
Int J Cardiol; 2014 Jul; 174(3):794-6. PubMed ID: 24794057
[No Abstract] [Full Text] [Related]
20. Arrhythmogenic Cardiomyopathy.
Corrado D; Basso C; Judge DP
Circ Res; 2017 Sep; 121(7):784-802. PubMed ID: 28912183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
